t

Automating the Cloud: AWS Tools and Tips

Sharing third-party AWS workflow options that can be integrated to increase your operation's effectiveness and productivity when working in the cloud. 

Keep on reading: Automating the Cloud: AWS Tools and Tips




t

M.R. Asks 3 Questions: Jay Chapel, CEO, ParkMyCloud

The challenges businesses and services are facing right now vary from wild fluctuations in supply chains; to enormous digital demand on the technologies and platforms that enable us to stay connected and live productive lives. This is why Jay Chapel is looking for ways to help organizations reduce costs across the board. Collecting information from great companies, we hope our conversation shares some ideas that may help in some small way.

Keep on reading: M.R. Asks 3 Questions: Jay Chapel, CEO, ParkMyCloud




t

FDA AMENDS THE DEFINITION OF “BIOLOGICAL PRODUCT” AND PREPARES FOR THE CONCLUSION OF A DECADE-LONG TRANSITION PERIOD

By Jennifer A. Davidson and Justine E. Johnson On February 21, 2020, FDA published a final rule that, effective March 23, 2020, amends the regulatory definition of “biological product” consistent with the statutory definition under the Biologics Price Competition and Innovation Act of 2009 (BPCIA), as amended by the Further Consolidated Appropriations Act, 2020 (FCAA),

The post FDA AMENDS THE DEFINITION OF “BIOLOGICAL PRODUCT” AND PREPARES FOR THE CONCLUSION OF A DECADE-LONG TRANSITION PERIOD appeared first on Kleinfeld Kaplan & Becker LLP.




t

FDA Waives Certain Adverse Event Reporting Deadlines Across Product Industries During Pandemics

By Suzan Onel and Vanessa Fulton On March 19, 2020, FDA issued a guidance document communicating its policy regarding postmarket adverse event reporting during a pandemic (“Guidance”).  The Guidance provides recommendations that affect adverse event reporting obligations for drugs, biologics, medical devices, combination products, and dietary supplements. To summarize, FDA states in the Guidance that

The post FDA Waives Certain Adverse Event Reporting Deadlines Across Product Industries During Pandemics appeared first on Kleinfeld Kaplan & Becker LLP.




t

It’s Not Always Easy Being Green – Lawsuit Related to “Recyclable” Claims Highlights Risks Related to Environmental Benefit Claims

By: Jacqueline Chan and Vanessa Fulton Consumers are increasingly demanding environmentally-friendly products and packaging.  Driven by this increased demand and desire to create positive environmental change, companies are working hard to shift to more sustainable materials and packaging and seeking to communicate such efforts to consumers through product labels and advertising.  “Recyclable.”  “Biodegradable.”  “Made of

The post It’s Not Always Easy Being Green – Lawsuit Related to “Recyclable” Claims Highlights Risks Related to Environmental Benefit Claims appeared first on Kleinfeld Kaplan & Becker LLP.




t

FDA ISSUES FINAL RULE ON GRAPHIC WARNINGS FOR CIGARETTE PACKAGES AND ADVERTISEMENTS

By: Stacy Ehrlich and Justine E. Johnson On March 18, 2020, the Food and Drug Administration (FDA) published a final rule (21 C.F.R. Part 1141) requiring textual and graphic health warnings to be included on all cigarette packages and advertisements.[1]  FDA simultaneously published two related guidance documents: (1) Required Warnings for Cigarette Packages and Advertisements,

The post FDA ISSUES FINAL RULE ON GRAPHIC WARNINGS FOR CIGARETTE PACKAGES AND ADVERTISEMENTS appeared first on Kleinfeld Kaplan & Becker LLP.




t

Shortage of PPE and other Devices During COVID-19 Pandemic – Is 3D Printing the Answer?

By: Suzan Onel FDA issued a Press Release on March 28, 2020, reiterating what we all have seen in the news, there is a severe shortage of personal protective equipment (PPE) in health care facilities across the country.  In response to the shortages, FDA has issued Emergency Use Authorizations (EUAs) for respirators, ventilators, ventilator tubing

The post Shortage of PPE and other Devices During COVID-19 Pandemic – Is 3D Printing the Answer? appeared first on Kleinfeld Kaplan & Becker LLP.




t

New Opportunities for OTC Monograph Drugs under the CARES Act

By: Daniel Dwyer and Daniel Logan On March 27, 2020, the President signed into law the Coronavirus Aid, Relief, and Economic Security Act, or “CARES” Act (Pub. Law 116-136), which includes a comprehensive revision of the rules governing over-the-counter (OTC) drugs currently marketed under monographs published by the Food and Drug Administration (FDA).  This law

The post New Opportunities for OTC Monograph Drugs under the CARES Act appeared first on Kleinfeld Kaplan & Becker LLP.




t

Changes Made to the Federal Food, Drug, and Cosmetic Act by the CARES Act

By: Daniel Logan and Justine Johnson The Coronavirus Aid, Relief, and Economic Security Act, or “CARES” Act (Pub. L. No. 116–136) makes numerous changes to the Federal Food, Drug, and Cosmetic Act (FDCA).  The CARES Act made substantial changes related to the regulation of over-the-counter (OTC) drugs (see KKB’s alert here dedicated to summarizing these

The post Changes Made to the Federal Food, Drug, and Cosmetic Act by the CARES Act appeared first on Kleinfeld Kaplan & Becker LLP.




t

LIVE WEBINAR: Hemp & CBD: FDA Update and the Impact of COVID-19

Join Kleinfeld, Kaplan & Becker, LLP and Vicente Sederberg on Tuesday, April 7 at 2:15 p.m. ET for a live webinar on Hemp and CBD – FDA Update and the Impact of COVID-19. Since 2015, KKB and VS have worked closely together in advising clients on the ever-evolving legal landscape for hemp-derived products. During this

The post LIVE WEBINAR: Hemp & CBD: FDA Update and the Impact of COVID-19 appeared first on Kleinfeld Kaplan & Becker LLP.




t

TTB Finalizes Portions of Modernization of Advertising and Labeling Regulations for Wine, Distilled Spirits, and Malt Beverages Rule

#TTB just made changes to modernize the way that #wine, #distilledspirits, and #maltbeverages are labeled and advertised. KKB associate Dan Logan and partner Dan Dwyer highlight some of the key changes (and proposals that were rejected).

The post TTB Finalizes Portions of Modernization of Advertising and Labeling Regulations for Wine, Distilled Spirits, and Malt Beverages Rule appeared first on Kleinfeld Kaplan & Becker LLP.




t

KLEINFELD, KAPLAN & BECKER WELL REPRESENTED ON THE WASHINGTON, DC, 2020 SUPER LAWYERS LIST FOR “FOOD AND DRUGS”

We are pleased to announce that KKB partners Dan Dwyer, Stacy Ehrlich, Peter Mathers, and Suzan Onel were selected for the annual Super Lawyers list for Washington, DC.  They make up more than 20% of the 18 DC attorneys listed in the “Food and Drugs” category.  In addition, for the sixth year in a row, KKB

The post KLEINFELD, KAPLAN & BECKER WELL REPRESENTED ON THE WASHINGTON, DC, 2020 SUPER LAWYERS LIST FOR “FOOD AND DRUGS” appeared first on Kleinfeld Kaplan & Becker LLP.




t

COVID─19 pandemic leads to rise in circulation of counterfeit drugs




t

Indian analytical instruments industry expects low govt funding & curtailed Capex in post─COVID─19 phase




t

DCGI extends validity of registration of BA/BE study centres




t

NIAB develops portable 'ECovSens' tool for diagnosis of COVID─19 antigens from saliva




t

DCGI grants approval to PGIMS, Rohtak to start clinical trials on BCG vaccine for treatment of COVID─19




t

Potential of Ayurveda should not be ignored in the fight against COVID─19: Dr Saravadekar




t

KRPA urges state govt to bring pharmacists under insurance cover on lines of healthcare workers engaged in treating COVID─19 patients




t

PPE suppliers providing unauthentic certificates to buyers including govt procurement agencies




t

PCI assures govt of services of pharmacists as health workers in case COVID─19 cases rise alarmingly




t

Union health minister directs all states to ensure uninterrupted voluntary blood donation




t

Pradhanmantri Jan Aushadhi Kendras achieve record sales of Rs. 52 crore in April 2020




t

Pune's Ayush CoE, CRD & Dr DY Patil Univ to propel possible potential of Ayurveda─Yoga as preventive medicine for COVID─19




t

Ayurvedic drug Zingivir─H gets approval for clinical trial to treat COVID─19 patients




t

Finance ministry set to extend anti─dumping duty on import of sodium citrate from China




t

Maharashtra FDA allays fears of shortage of HCQ tabs either in govt hospital pharmacies or in retail pharmacies




t

FPME hails proactive measures by Centre to assist trade & industry to tide over crisis induced by COVID─19 pandemic




t

MTaI urges govt to provide relief to medical devices cos to come out of COVID─19─induced financial crisis and logistics bottlenecks




t

AIOCD urges govt to provide insurance cover to chemists to strengthen fight against COVID─19




t

DCGI directs state DCs to take stock of issues in procurement & prices of HCQ, azithromycin and paracetamol APIs




t

Maharashtra FDA issues licenses to 7 more cos to produce medical oxygen for treating critically ill COVID─19 patients




t

Indian pharma & machinery sector sees Smart Factory model to mitigate future challenges of COVID─19 like lockdowns




t

WBPC soon to open DIC at Council office to provide information on medication & safety measures to combat COVID─19




t

Health ministry releases guidelines on management of COVID─l9 suspect or confirmed cases in govt earmarked railway coaches




t

Union health minister calls upon all scientific depts to develop enhanced synergy for better results




t

Gujarat pharma industry upbeat as around 900 out of 1,100 plants start operations despite lockdown




t

IMA Sirsa unit issues notice to pharma cos to restrain field staff from meeting doctors till May 31 for product promotion




t

ICMR notifies NIMHANS as mentor institution for RT─PCR test protocol for COVID─19




t

TS health dept contemplating to home deliver medicines to patients suffering from chronic diseases




t

Gujarat FDCA initiates action against 2 companies based in Patan and Ahmedabad for illegal sale of drugs




t

Allmpus Labs to focus on increasing R&D in new drug discovery and development




t

3D Printed Microscope Costs as Little as $18

Researchers at the University of Bath in the UK have developed a 3D-printed microscope design, called OpenFlexure, which is open-source and can be assembled for as little as $18. More complex versions of the design are possible, and the microscope can incorporate full automation and a Raspberry Pi computer. The research team hopes that the […]




t

Soft Actuator and Sensor for Underactive Bladder Treatment

Researchers at the National University of Singapore have developed a soft sensor and actuator to monitor bladder volume and help empty it on-demand. The device is intended to be implanted on the bladder surface during a surgical procedure to treat patients who cannot completely empty their bladders voluntarily. Patients can suffer from an underactive bladder […]




t

Supersaturated Oxygen Therapy Cleared in EU to Treat Widowmaker Heart Attacks

ZOLL Medical, a part of the Asahi Kasei Group, won EU clearance for its SuperSaturated Oxygen (SSO2) Therapy System to be used to minimize the damage that heart attacks cause within heart muscle. Approved about a year ago in the United States, SSO2 is the only option beyond percutaneous coronary intervention (stenting) that can help […]




t

Stanford Bioengineers Innovate Multiple Solutions to Tackle COVID-19

The current pandemic is revealing the level of commitment needed from multiple sectors to deliver innovative solutions to tackle severe shortages of personal protective equipment, ventilators, and raw materials. Researchers at the Prakash lab at Stanford University are no stranger to taking up extreme challenges, and they have kept up their reputation by coming up […]




t

Aquadex Ultrafiltration for Critical COVID Patients: Interview with John Erb, CEO at CHF Solutions

As the COVID-19 pandemic continues, many healthcare facilities around the world are inundated with critically ill patients, and resources such as equipment and staff are stretched thin. Shortages of critical equipment, such as ventilators, can mean the difference between life and death for patients, and the need to keep critically ill patients comfortable and alive […]




t

New Fluorescence Microscopy Technique for Nanostructure Visualization Within Cells

Researchers at Purdue University have developed a new technique to dramatically enhance the resolution achievable when imaging intracellular structures with super-resolution fluorescence microscopy. The technique uses the distortions created by a specimen to pinpoint the location of individual molecules, and thereby infer the location of intracellular structures. The technique could be particularly useful in studying […]




t

BioButton to Help Track COVID, Ensure Safe Return to Work

BioIntelliSense, a Silicon Valley company, is unveiling its FDA cleared BioButton device that may help with tracking symptoms of COVID-19 in potential patients and help society return to a normal state of affairs. The BioButton is about the size of a large coin and, with the help of accompanying applications and triage dashboards, it can […]




t

A Multinational Effort to Reduce Neonatal Mortality: Interview with Dr. Maria Oden, Co-director of Rice 360° Institute for Global Health

According to the World Health Organization, 47% of childhood deaths worldwide occur in the first four weeks of life. This neonatal mortality rate is particularly prevalent in sub-Saharan Africa, where nearly one million newborns die every year. Many of these deaths can be prevented with medical devices that more developed countries often take for granted, […]